[HTML][HTML] CX3CR1 acts as a protective biomarker in the tumor microenvironment of colorectal cancer

Y Yue, Q Zhang, Z Sun - Frontiers in immunology, 2022 - frontiersin.org
The tumor microenvironment (TME) plays an important role in the pathogenesis of many
cancers. We aimed to screen the TME-related hub genes of colorectal adenoma (CRAD) …

[HTML][HTML] CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer

Y Yue, Q Zhang, Z Sun - Frontiers in Immunology, 2021 - ncbi.nlm.nih.gov
The tumor microenvironment (TME) plays an important role in the pathogenesis of many
cancers. We aimed to screen the TME-related hub genes of colorectal adenoma (CRAD) …

CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.

Y Yue, Q Zhang, Z Sun - Frontiers in Immunology, 2022 - europepmc.org
The tumor microenvironment (TME) plays an important role in the pathogenesis of many
cancers. We aimed to screen the TME-related hub genes of colorectal adenoma (CRAD) …

CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer

Y Yue, Q Zhang, Z Sun - Frontiers in immunology, 2022 - pubmed.ncbi.nlm.nih.gov
The tumor microenvironment (TME) plays an important role in the pathogenesis of many
cancers. We aimed to screen the TME-related hub genes of colorectal adenoma (CRAD) …

CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer

Y Yue, Q Zhang, Z Sun - Gastrointestinal Cancer Immune …, 2022 - books.google.com
Yue et al. Role of CX3CR1 in CRC tumor differentiation, and prognosis. Our results suggest
that CX3CR1 contributes to the recruitment and regulation of immune-infiltrating cells and …

CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.

Y Yue, Q Zhang, Z Sun - Frontiers in Immunology, 2022 - europepmc.org
The tumor microenvironment (TME) plays an important role in the pathogenesis of many
cancers. We aimed to screen the TME-related hub genes of colorectal adenoma (CRAD) …